Account
Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

Insider Insights

Johnson & Johnson sues the US Government over …

J&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde…
Read more
Insider Insights

Worldwide: New Coalition to improve access to canc…

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin…
Read more
Case Study

With our extensive expertise, we are ideally posit…

We offer comprehensive bespoke market access training solutions, which are tailored to the individua…
Read more
Articles

Will the CDF proposals force pharma to prepare for…

Pharma companies must start preparing its NICE submission at the time of making the regulatory subm…
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you

Flexible

We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies

Responsive

We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

Insider Insights
24.07.2023
Johnson & Johnson sue the US government

J&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde…

Read more
Insider Insights
02.10.2023
AIFA Reform: CPR and CTS committees extended again

Discover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR …

Read more
Insider Insights
29.09.2023
Switzerland’s 2024 Medicine Access Reforms

Switzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an…

Read more
Insider Insights
21.09.2023
France’s €1B 2024 Reimbursement Savings Goal

French government’s ambitious plan to save €1 billion in healthcare expenses by 2024 through new r…

Read more
Insider Insights
14.09.2023
AMR Subscription Model Consultation by NHS England

Learn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial …

Read more
Insider Insights
12.09.2023
New Additions to HTA International Collaboration

In a ground breaking move, the international collaboration among six prominent health technology ass…

Read more
Articles
07.09.2023
HUMN legislation – enabler or barrier for advanc…

This article explores the new EU pharmaceutical package and criteria of high unmet medical need (HUM…

Read more
Articles
07.09.2023
Prescription Price Puzzles: The Sky-High Cost of O…

This article explores the significant disparities between the US and Europe regarding orphan drugs a…

Read more
Insider Insights
29.08.2023
CMS announces first 10 drugs to undergo price nego…

The Centers for Medicare and Medicaid Services has unveiled a list of 10 drugs to undergo Medicare p…

Read more
Insider Insights
17.08.2023
Managed entry agreements: €195m saved by the Ita…

MEAs resulted in 195.2 million of savings for the Italian healthcare system, according to AIFA’s M…

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.